Therapy-Related Trilineage Mixed Phenotype Acute Leukemia Treated with Venetoclax and Azacitidine

被引:0
|
作者
Yamamoto, Jotaro [1 ]
Yamaguchi, Kyosuke
Watanabe, Otoya
Kageyama, Kosei
Taya, Yuki
Kaji, Daisuke
Nishida, Aya
Uruga, Hironori
Takagi, Shinsuke
Ishiwata, Kazuya
Yamamoto, Hisashi
Masuda, Akiko
Takazawa, Yutaka
Yamamoto, Go
Mori, Yuki
Uchida, Naoyuki
Wake, Atsushi
机构
[1] Toranomon Hosp Kajigaya, Dept Hematol, Kawasaki, Japan
关键词
Mixed phenotype acute leukemia (MPAL); Myeloid neoplasm post cytotoxic therapy; Venetoclax; Azacitidine; Cord blood transplantation; STEM-CELL TRANSPLANTATION; MYELOID NEOPLASMS;
D O I
10.2169/internalmedicine.4898-24
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This is the first report of therapy-related mixed-phenotype acute leukemia (MPAL) characterized by B-cell, T-cell, and myeloid lineage phenotypes. A 68-year-old man, who was in complete remission after chemoradiotherapy for recurrent esophageal cancer, developed bacterial pneumonia with increasing blasts in the peripheral blood, and a subsequent bone marrow biopsy revealed 85.2% blasts. A flow cytometric analysis revealed cytMPO+, CD19+, cytCD22+, and cytCD3+ markers. The patient was diagnosed with therapy-related MPAL (B/T/myeloid lineage). After the initiation of venetoclax and azacitidine, the patient achieved complete remission, and cord blood transplantation was performed. This case provides novel insights into the therapeutic options for therapy-related trilineage MPAL treatment.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Therapy-related acute promyelocytic leukemia
    Ravandi, Farhad
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (04): : 493 - 495
  • [22] T/myeloid mixed-phenotype acute leukemia treated with venetoclax and decitabine: A case report
    Park, Sungwoo
    Jeong, Eun Jeong
    Kang, Jung Hun
    Lee, Gyeong-Won
    Go, Se-Il
    Lee, Dong-Hyun
    Koh, Eun-Ha
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (26) : 6200 - 6205
  • [23] Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumab
    Khalid Shoumariyeh
    Johannes Jung
    Michael Rassner
    Sandra Maria Dold
    Veronika Riebl
    Milena Pantic
    Georg Herget
    Reinhard Marks
    Michael Lübbert
    Ralph Wäsch
    Monika Engelhardt
    Annals of Hematology, 2021, 100 : 1637 - 1640
  • [24] Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumab
    Shoumariyeh, Khalid
    Jung, Johannes
    Rassner, Michael
    Dold, Sandra Maria
    Riebl, Veronika
    Pantic, Milena
    Herget, Georg
    Marks, Reinhard
    Lubbert, Michael
    Wasch, Ralph
    Engelhardt, Monika
    ANNALS OF HEMATOLOGY, 2021, 100 (06) : 1637 - 1640
  • [25] The Clinical Tumor Lysis Syndrome in a Patient with Mixed Phenotype Acute Leukemia Undergoing Induction with Venetoclax and Azacitidine: A Case Report
    Drozd-Sokolowska, Joanna
    Madry, Krzysztof
    Siewiorek, Kinga
    Feliksbrot-Bratosiewicz, Magdalena
    Stoklosa, Tomasz
    Gierej, Beata
    Stefaniak, Agnieszka
    Paszkowska-Kowalewska, Malgorzata
    Sokolowski, Jacek
    Sankowski, Bartlomiej
    Basak, Grzegorz Wladyslaw
    CHEMOTHERAPY, 2022, 67 (03) : 173 - 177
  • [26] Treatment with Blinatumomab in Combination with Venetoclax for Mixed Phenotype Acute Leukemia
    Wu, Xiaoxia
    Yang, Zhen
    Lu, Shenqi
    Zhang, Xinhui
    Wu, Depei
    Sun, Aining
    Miao, Miao
    Zhou, Huifen
    BLOOD, 2023, 142
  • [27] Therapy-related leukemia in mitozantrone treated patients
    Goodkin, DE
    MULTIPLE SCLEROSIS, 2003, 9 (04): : 426 - 426
  • [28] Case report: Positive response to venetoclax and azacitidine in the treatment of acute myeloid leukemia with myelodysplasia-related changes and blasts of the mixed T/myeloid phenotype
    Wen, Xiaojia
    Yu, Jiaole
    Fan, Jia
    Zhu, Shuai
    Zheng, Huyong
    PEDIATRIC BLOOD & CANCER, 2024, 70 (11)
  • [29] Venetoclax-azacitidine as salvage therapy for relapsed mixed phenotype acute leukemia after a second allogeneic hematopoietic stem cell transplantation: a case report
    Mekni, Sabrine
    Kanoun, Rimmel Yosra
    Ladeb, Saloua
    Belloumi, Dorra
    Ben Abdeljelil, Nour
    Ben Othman, Tarek
    BLOOD RESEARCH, 2023, 58 (02) : 118 - 120
  • [30] A CASE OF RELAPSED REFRACTORY ACUTE MYELOID LEUKEMIA WHO WAS ABLE TO BE TREATED AT HOME WITH VENETOCLAX/AZACITIDINE COMBINATION THERAPY
    Yamashita, Yoshiharu
    Hino, Moeko
    Okunushi, Tomoko
    Aoki, Takahiro
    Chikaraishi, Koji
    Hamada, Hiromichi
    PEDIATRIC BLOOD & CANCER, 2022, 69